Welcome to South West Healthcare
Leaders in healthcare, partners in wellbeing.
Please use this identifier to cite or link to this item:
https://repository.southwesthealthcare.com.au/swhealthcarejspui/handle/1/4231| Journal Title: | Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial |
| Authors: | Chia, John W K Segelov, Eva Deng, Yanhong Fuang Ho, Gwo Wang, Wei Han, Shuting Sharma, Atul Ding, Kefeng Chen, Gong Jeffery, Mark G Kian Tham, Chee Nott, Louise Bae Ahn, Joong Zielinski, Robert Chao, Tsu-Yi Van Hagen, Tom Wei, Po-Li Day, Fiona Mehta, Shaesta Yau, Thomas Peng, Jiewen Li, Yong Gandhi, Mihir Foo MCouns, Estelle M J Rahman, Nabilah Rothwell, Peter Ali, Raghib Simes, John Chong Toh, Han |
| SWH Author: | Hayes, Theresa M |
| Keywords: | Aspirin Colorectal Cancer Trial Placebo Medication Efficiency Dukes B |
| Issue Date: | Mar-2025 |
| Date Accessioned: | 2025-02-17T00:14:20Z |
| Date Available: | 2025-02-17T00:14:20Z |
| Accession Number: | S2468-1253(24)00387-X |
| Url: | https://doi.org/10.1016/S2468-1253(24)00387-X |
| Format Startpage: | 198 |
| Source Volume: | 10 |
| Issue Number: | 3 |
| Database: | ScienceDirect |
| DOI: | 10.1016/S2468-1253(24)00387-X |
| Abstract: | Aspirin is a simple, globally available medication that has been shown to reduce the incidence of colorectal cancer. We aimed to evaluate the safety and efficacy of aspirin in the secondary prevention of colorectal cancer. |
| URI: | https://repository.southwesthealthcare.com.au/swhealthcarejspui/handle/1/4231 |
| Journal Title: | The Lancet Gastroenterology & Hepatology |
| ISSN: | 2468-1156 Online 2468-1253 Print |
| Type: | Journal Article |
| Appears in Collections: | SWH Staff Publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.